Usfda: Latest News and Updates, Top Stories, Videos, Photos About Usfda

182% Rise In 1-Yr: Pharma Stock Jumps On USFDA Approval for Gabapentin Tablets USP

Small cap pharmaceuticals sector company Strides Pharma Science Ltd shares zoomed 3.49% intraday today soon after its step‐ down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, obtained approval for Gabapentin Tablets USP, 600 mg and 800 mg, from the ...

Lupin Gets USFDA Nod For Febuxostat Tablets, Shares Hit 52-Week High For 2nd Day

Lupin Ltd shares traded fresh 52-week high on Friday after the global pharma major on January 18 announced of receiving approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Febuxostat Tablets, 40 ...

Cipla Stock Plunges After USFDA Warning; Elara Capital Optimistic On US Prospects

Cipla Ltd, the prominent Mumbai-based pharmaceutical company, witnessed a sharp decline in its shares on Thursday, emerging as the top losers on the Nifty 50 index. The plunge followed the disclosure by the United States Food & Drug Administration (USFDA) of ...

New 52-Week High: SmallCap Stock Strides Pharma Jumps Over 11% On USFDA Approval

Bengaluru-based drugmaker, Strides Pharma Science witnessed an impressive buying on Friday as the smallcap stock jumped over 11% to touch a new 52-week high. The strong bulls appeared after the pharma company's step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, ...

Zydus Life Receives Final USFDA Approval, For Insomnia Drug

Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator to market its generic version of Triazolam tablets used on a short-term basis to treat insomnia. The approval granted by the US Food and Drug ...

Aurobindo Pharma Receives "Warning Letter" From SEBI Over USFDA Audit Row

Today, June 27, Aurobindo Pharma, a pharmaceuticals company, informed the stock exchanges that it had received a "warning letter" from the Securities and Exchange Board of India (SEBI) regarding the US Food and Drug Administration (USFDA) audit at its Hyderabad facility. ...

USFDA Issues 13 Observations, To Lupin's Novel Laboratories

Pharma major Lupin Ltd on Thursday said the USFDA has issued 13 observations to its US-based wholly-owned subsidiary Novel Laboratories, Inc after an inspection. The USFDA (US Food and Drug Administration) has concluded an inspection at the company's wholly-owned ...

Unichem Laboratories, Gets USFDA Nod For Generic Nebivolol Tablets

Unichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic version of Nebivolol tablets indicated for the treatment of hypertension. The approval by the US Food and Drug Administration (USFDA) for ...

Ranbaxy lowers its net loss to Rs 158.5 crores in Q4

Pharma major Ranbaxy Laboratories Ltd today reported a drastic drop in net loss at Rs 158.48 crore during the fourth quarter ended December 31, 2013. Total income from operations of the company rose to Rs 2,893.99 crore from Rs 2,711.21 ...

USFDA increases inspections of drug facilities in India

NEW DELHI: The US Food and Drug Administration (USFDA) is increasing its inspections of facilities of drug makers in India, the second largest provider of finished dose products to the US, to ensure compliance of approved manufacturing norms. The US ...

Lupin share up on USFDA approval for its contraceptive drug Norethindrone

Lupin's share went up as it received the US regulatory approval to launch oral contraceptive tablets Norethindrone. The tablets are generic version of Watson Pharmaceuticals' brand Nor-QD and have annual sales of about $52 million in the US. News ...

Usfda News